Animals exploit different germ-line-encoded proteins with various domain structures to detect the signature molecules of pathogenic microbes. These molecules are known as pathogen-associated molecular patterns (PAMPs), and the host proteins that react with PAMPs are called pattern recognition proteins (PRPs). Here, we present a novel type of protein domain structure capable of binding to bacterial peptidoglycan (PGN) and the minimal PGN motif muramyl dipeptide (MDP). This domain is designated as apextrin C-terminal domain (ApeC), and its presence was confirmed in several invertebrate phyla and subphyla. Two apextrin-like proteins (ALP1 and ALP2) were identified in a basal chordate, the Japanese amphioxus Branchiostoma japonicum (bj). bjALP1 is a mucosal effector secreted into the gut lumen to agglutinate the Grampositive bacterium Staphylococcus aureus via PGN binding. Neutralization of secreted bjALP1 by anti-bjALP1 monoclonal antibodies caused serious damage to the gut epithelium and rapid death of the animals after bacterial infection. bjALP2 is an intracellular PGN sensor that binds to TNF receptor-associated factor 6 (TRAF6) and prevents TRAF6 from self-ubiquitination and hence from NF-κB activation. MDP was found to compete with TRAF6 for bjALP2, which released TRAF6 to activate the NF-κB pathway. BjALP1 and bjALP2 therefore play distinct and complementary functions in amphioxus gut mucosal immunity. In conclusion, discovery of the ApeC domain and the functional analyses of amphioxus ALP1 and ALP2 allowed us to define a previously undocumented type of PRP that is represented across different animal phyla.
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pattern recognition receptor | immune response | NF-κB signaling pathway T he innate immune system plays an essential role in the first line of host defense against pathogenic microbes. Microbes express signature molecules known as pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharide (LPS) in Gram-negative bacteria, peptidoglycan (PGN) and lipoteichoic acid (LTA) in Gram-positive bacteria, mannan in yeast, double-stranded RNA in viruses, and unmethylated CpG motifs in bacteria, which are essential for survival and hence difficult for microbes to change via adaptive evolution (1, 2) . The innate immune system relies on germ-line-encoded pattern recognition proteins (PRPs) to detect and react with PAMPs. A variety of PRPs based on different protein domain structures with distinct PAMP specificities have been discovered in animals, including Toll-like receptors (TLRs), nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs), RIG-I-like receptors (RLRs), scavenger receptors, C-type lectin receptors (CLRs), peptidoglycan recognition proteins (PGRPs), Gramnegative bacteria-binding proteins (GNBPs), siglecs, beta2-integrins, collectins, and ficolins (3) (4) (5) (6) (7) . Some PRP families serve as dedicated sensors (e.g., TLRs and RLRs), and the others are exclusive effectors (e.g., collectins and ficolins), or both (e.g., CLRs and PGRPs). Sensor PRPs can be intracellular sensors (e.g., NLRs and RLRs), extracellular sensors (e.g., PGRPs and GNBPs), or both (e.g., TLRs) (3-7). Some PAMPs are recognized outside the cells by cell-surface receptors, whereas others are recognized intracellularly after the PAMPs have entered the cell. For example, LPS is recognized by cell-surface receptor TLR4, and muramyl dipeptide (MDP) is recognized by NOD2 in the intracellular space (1, 2) .
Pathogen recognition by sensor PRPs may initiate coordinated immune responses at the molecular, cellular, tissue, and organ levels (8) . The NF-κB family of transcription factors plays a central role in regulating the responses triggered by many PRPs, including TLRs, NLRs, and RLRs (9, 10) . TNF receptor-associated factor 6 (TRAF6) is a crucial intermediate signal transducer for activating NF-κB in response to the signaling of TLRs, NLRs, RLRs, and TNF receptors (11, 12) . During signaling, TRAF6 is activated by upstream adaptors [e.g., Myeloid differentiation primary response gene (88) (MYD88) and Tolllike receptor adaptor molecules] and kinases (e.g., IL-1 receptor-associated kinases and receptor-interacting serine-threonine kinases) (10, 11) and acts as an E3 ubiquitin ligase to catalyze Lys-63-linked polyubiquitination on itself as well as on IκB kinase γ (13). TGF-beta-activated kinase 1 (TAK1) and its binding proteins TAB2 and TAB3 are then recruited to TRAF6; TAK1 then activates downstream IκB kinases, ultimately leading to NF-κB activation (14, 15) . TRAF6-depedent NF-κB activation is not only important to the vertebrate immune system but is also
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Microbial specific pathogen-associated molecular patterns (PAMPs) constitute a key feature by which a host organism detects the presence of microbes and mounts specific immune responses. Here, we report the discovery of two proteins (bjALP1 and 2) that interact with muramyl dipeptide, a panbacterial specific PAMP via a novel pattern recognition domain ApeC. Our studies have revealed that bjALP1 is a secreted immune effector, whereas bjALP2 functions as an intracellular pattern recognition receptor (PRR), both having an important role in protecting the host from microbial pathogens. Specifically, bjAPL1 functions in the extracellular space to reduce the harmful effect of pathogenic microbes, whereas bjALP2 functions as a PRR that serves as a sentinel for intracellular bacterial invasion. Data deposition: The sequences reported in this paper have been deposited in the GenBank database (accession nos. KM017614 and KM017615) and the Pfam database (accession no. PF16977, which will be available in the v28.0 release). indispensable for the Toll and Imd antimicrobial signaling pathways in Drosophila (16, 17) .
Amphioxus represents the basal living chordate lineage that diverged from two other lineages (urochordates and vertebrates) ∼550 Mya (18) . This chordate invertebrate underwent no wholegenome duplications, shares extensive genomic conservation with vertebrates, and is one of the best proxies for understanding the chordate ancestral immune gene system (19) (20) (21) (22) . Amphioxus has not be found to contain molecular hallmarks of adaptive immunity, including antigen receptors and MHC molecules, but it has a much stronger innate immune gene system, which contains nearly 10 times more receptor and mediator genes than in humans and is tightly regulated during immune responses (22, 23) . To date, several amphioxus PRPs have been verified as antimicrobial effectors, including a CLR, a ficolin, and a C1q-like protein (24) (25) (26) . Functional analyses show that amphioxus also relies on the conserved TLR-MyD88-NF-κB and TRAF6-NF-κB/IκB pathways to regulate immune responses (27) (28) (29) .
Here, we report two proteins from the amphioxus Branchiostoma japonicum (bj) that contain the ApeC domain, a novel pattern recognition domain for MDP, a bacterial-specific PAMP. The proteins share high similarity with the C-terminal regions of the apextrin proteins that were first identified in sea urchins (30, 31) . We designate this domain apextrin C-terminal domain (ApeC) and named them apextrin-like protein 1 and 2 (bjALP1 and bjALP2). Functional analyses showed that bjALP1 acted as an extracellular effector for bacterial agglutination, whereas bjALP2 could mediate intracellular bacterial recognition and NF-κB activation. We therefore demonstrate that these ApeCcontaining proteins represent a previously unidentified family of immune response proteins that have important roles in antimicrobial defense.
Results
ALPs and the Novel ApeC Domain. In this study, we cloned two full-length cDNA sequences from amphioxus B. japonicum (bj), encoding a 504-aa protein (bjALP1) and a 462-aa protein (bjALP2). The two proteins share 54% sequence identity and both consist of a signal peptide, an N-terminal spacer region, and a C-terminal region of ∼200 aa (Figs. S1 and S2). A database search revealed that putative ApeC-containing proteins were presence in many invertebrate species, but no clear or unambiguous homologs were found in Caenorhabditis elegans, fruit flies, urochordates, or vertebrates (Fig. S3A) . Thus, it seems that bjALP1 and 2 are membersof a group of ApeC-containing proteins that are uniquely prevalent in the invertebrate phyla. Phylogenic analysis shows that there are no cross-(sub)phylum orthologs found between ALPs (Fig. S3B) .
Gene Expression Patterns of bjALP1 and bjALP2. A quantitative realtime PCR (qRT-PCR) analysis showed that in adult animals bjALP1 mRNA was more highly expressed than bjALP2 in all six tissues examined, including gill, hepatic cecum, intestine, skin, muscle, and ovary ( Fig. 1 A and B) . Both genes showed the highest expression in the hepatic cecum and skin, whereas bjALP1 also had substantial expression in the gill and intestine. Section in situ hybridization confirmed the mRNA distribution of both genes in the digestive tract, skin, and ovary and the higher expression level of bjALP1 than of bjALP2 ( Fig. 1 C and  D) . We further found that in the gut of adult animals the mRNA expression of both ALP genes was highly unregulated during acute antibacterial responses. BjALP1 showed an astounding 3,700-fold induction at 12 h after Gram-negative Vibrio anguillarum infection and 2,759-fold induction at 24 h after Grampositive Staphylococcus aureus infection, whereas the peak upregulation of bjALP2 was approximately 10 times weaker than that of bjALP1 ( Fig. 1 E and F) . These data suggest that bjALP1 is more strongly expressed and induced compared with bjALP2 and that both genes might be involved in gut mucosal immunity.
Bacterial Agglutination Mediated by bjALP1 and bjALP2. This extremely high expression and induction during infection led us to suspect that bjALP1 encodes a secreted mucosal effector. We purified recombinant His-tagged bjALP1 and bjALP2 proteins and incubated them with 10 different bacterial strains. After incubation, the bacterial pellets were washed and analyzed by Western blotting with anti-His monoclonal antibodies, which showed that both recombinant proteins could bind to Grampositive bacteria with different affinities but not to Gram-negative bacteria ( Fig. 2A) . We then incubated the bjALP1 and bjALP2 recombinant proteins with FITC-labeled bacteria to determine the bacterial aggregation effect. The results showed that the recombinant proteins caused significant aggregation of the Gram-positive bacteria Enterococcus faecium and S. aureus, but not Gram-negative E. coli (Fig. 2B) . Quantification of the diameter of green bacterial puncta suggested that the aggregation effect was stronger for S. aureus than for E. faecium (Fig.  S4A) . Intriguingly, however, we could not detect a significant bactericidal activity from recombinant bjALP1 (Fig. S4 B and C) .
bjALP1 and bjALP2 Bind PGN Through the ApeC Domain. We used enzyme-linked immunosorbent assay (ELISA) to evaluate the In situ hybridization of bjALP2 in adult female sections; the sense probe was used as the negative control. e, endostyle; g, gill; hc, hepatic cecum; i, intestine; m, muscle; nc, notochord; o, ovary; s, skin; sc, spinal cord. (E and F) The relative expression level of ALP mRNA in hepatic ceca and intestine after challenge with V. anguillarum and S. aureus was determined by qRT-PCR analysis. The data are shown as a ratio to the ALP mRNA expression level after the injection of PBS and are plotted as the means ± SD; *P < 0.05, **P < 0.01, ***P < 0.001.
interaction between the bjALP1 and bjALP2 recombinant proteins and different bacterial cell wall components. Both bjALP1 and bjALP2 could interact with soluble PGN from S. aureus and E. coli but not with soluble LPS, LTA, zymosan, or mannan (Fig.  3A) . Pull-down assays confirmed that both recombinant proteins directly bound with insoluble PGN from S. aureus and E. coli in a dose-dependent manner (Fig. 3B) . Indeed, both bjALP1 and 2 could bind specifically to MDP, the minimal PGN motif (Fig.  3C) . The interaction was investigated further by using mutant bjALP1 or 2 that either lacks the ApeC domain (bjALP1ΔC, bjALP2ΔC) or the N-terminal spacer domain (bjALP1ΔN,  bjALP2ΔN) . The results showed that only the bjALP1ΔN and bjALP2ΔN recombinant proteins could bind with PGN and MDP (Fig. 3 D and Fig. S5 ), suggesting that ApeC is required for PGN/MDP recognition. Taken together, we concluded that both bjALP1 and bjALP2 are capable of agglutinating Gram-positive bacteria via interaction between the ApeC domain and the bacterial cell-wall component PGN/MDP. However, because the MDP moieties are exposed at the cell surface of Gram-positive but not of Gram-negative bacterium (32), bjALP1 or bjALP2 could only bind efficiently to Gram-positive and not to Gramnegative bacterium (Fig. 2A) .
Distribution of the Endogenous bjALP1 and bjALP2 Proteins. We produced anti-bjALP1 and anti-bjALP2 monoclonal antibodies (mAbs) using the peptides 412 GEVPDGNYDR  421 and   375   DGIYNRNTEI   384 , respectively (Fig. S6) . We performed immunogold analysis of hepatic ceca of amphioxus with these antibodies and found that gold particles localize bjALP1 mainly in mucus, with some scattered signals in cytoplasm (Fig. 4 A and B) , whereas for bjALP2 most of the gold particles were distributed near plasma membrane in the cytoplasm side (Fig. 4 C and D and 7 cfu/mL) in PBS for 1 h at room temperature and were examined using fluorescence microscopy. Background absorbance without protein was subtracted. *P < 0.05, **P < 0.01, ***P < 0.001. Fig. S7 A and B) . In the excrement of these animals, which mainly consisted of mucus and S. aureus, we observed a large amount of bjALP1 surrounding the bacteria (Fig. 4E) . In contrast, no bjALP2 was detected in the excrement (Fig. 4F) . Western blotting confirmed the presence of bjALP1 and the absence of bjALP2 in the excrement of these bacterially fed animals (Fig. S7C ).
BjALP1 Protected Amphioxus from the Harmful Effect of Bacterial
Infections. Considering the abundance of bjALP1 in the feces of infected animals, the massive induction during bacterial infection, and the bacterial agglutination effect, we suspected that bjALP1 could be an indispensable extracellular effector of gut mucosal immunity. The anti-bjALP1 mAb is specific for the ApeC domain (412-421 aa) of bjALP1 and may interfere with the interaction between bjALP1 and PGN owing to steric hindrance. ELISA verified that the addition of the anti-bjALP1 mAb did reduce the binding of recombinant bjALP1 to MDP in a dose-dependent fashion (Fig. S8) . Therefore, anti-ALP1 mAb can be used to block the function of endogenous bjALP1 proteins in the gut of amphioxus. As shown in Fig. 5 A and B, oral feeding of the anti-ALP1 mAb significantly decreased the survival rates of adult amphioxus after bacterial infection. Tissue section examination showed that without the protection of extracellular bjALP1 the gill of infected amphioxus was completely destroyed by S. aureus infection within 72 h (Fig. 5 C-F) . Although bjALP2 proteins were present within gut epithelial cells, they could not be detected in the excrement of infected amphioxus. Also, a full-length bjALP2-enhanced GFP (EGFP) fusion protein, when ectopically expressed in HEK293T cells, was detected within the cells but not in the culture medium (Fig.  S7D) . The signal peptide of bjALP2 is clearly functional because fusing the bjALP2 signal peptide to the EGFP protein resulted in the secretion of EGFP (Fig. S7D) . Nonetheless, replacing bjALP2's original signal peptide with the signal peptides of Igκ and preprotrypsin also failed to induce bjALP2 secretion (Fig.  S7E) . Therefore, it seems that certain feature(s) of bjALP2 render its secretary signal peptide ineffective, leading to its cytoplasmic retention despite having a signal peptide. A sequence analysis revealed a potential TRAF6-binding motif in the N-terminal spacer region of bjALP2 (Fig. 6A) . We suspected that when retained in the cytoplasm bjALP2 might interact with amphioxus TRAF6 (bjTRAF6). Using luciferase reporter assays in HEK293T cells, we found that full-length bjALP2 strongly inhibited NF-κB activation induced by amphioxus MyD88 (bjMyd88) and bjTRAF6 in a dose-dependent manner (Fig. 6B) . Using two mutant constructs, bjALP2ΔC (lacking the ApeC domain) and bjALP2ΔN (lacking the N-terminal spacer region), we further showed that the NF-κB inhibitory activity of bjALP2 is mainly determined by its N-terminal spacer region (Fig. 6C) .
We then analyzed the subcellular location of bjALP2 and bjTRAF6. When coexpressed with the myc-tagged bjTRAF6 protein in HeLa cells, the bjALP2-EGFP fusion protein colocalized with myc-tagged bjTRAF6 in the cytoplasm (Fig. 6D) . We then constructed bjALP2ΔT6, a mutant without the TRAF6-binding motif. When overexpressed in HeLa cells, the subcellular localizations of bjALP2ΔT6 and bjALP2 were indistinguishable (Fig. S9 A and B) , suggesting that the TRAF6-binding motif has no obvious impact on the subcellular location of bjALP2. However, bjALP2ΔT6-EGFP failed to colocalize with myc-tagged bjTRAF6, suggesting that bjALP2 could not interact with bjTARF6 without the TRAF6-binding motif (Fig. S9C) . Indeed, coimmunoprecipitation (Co-IP) assays confirmed that bjALP2 interacted with bjTRAF6 when overexpressed in 293T cells (Fig.  6E) . Furthermore, mutation of the TRAF6-binding motif not only abolished the interaction between bjALP2 and bjTRAF6 but also relieved the inhibition of bjALP2 on NF-κB activation ( Fig. 6 E and F) .
The self-ubiquitination of TRAF6 is key event in NF-κB activation (13, 15) . Thus, to determine whether bjALP2 can interfere with the self-ubiquitination of bjTRAF6, we created two plasmid constructs containing Flag-tagged bjTRAF6 and HA-tagged bjUbiquitin, respectively. When these two constructs were cotransfected into HEK293T cells with the EGFP-tagged bjALP2 construct we recorded a significant reduction of the ubiquitination level of bjTRAF6 (Fig. 6G) .
MDP Could Relieve the Inhibition of bjALP2 on bjTRAF6. In mammals, whereas MDP is a PAMP that is recognized by NOD2, an intracellular pattern recognition receptor, MDP cannot cross the plasma membrane of mammalian cells efficiently through diffusion (33) . Interestingly, S. aureus, a microbial pathogen for amphioxus, could get into the intracellular space of the amphioxus gut epithelium shortly after being administered orally (34) . Together, these observations have suggested that MDP enters the cells as part of an intact microbe and hence serves as an excellent indicator for microbe intracellular invasion in amphioxus. In this context, our finding that bjALP2 also physically interacted with bjTRAF6 prompted us to speculate whether the interaction of bjALP2 with bjTRAF6, and accordingly the effect of TRAF6-mediated NF-κB activation, could be affected by MDP. Because we showed that bjALP2 is able to recognize PGN/MDP through its C-terminal ApeC domain, we sought to ascertain whether MDP can prevent bjALP2 from suppressing bjTRAF6. We therefore performed Co-IP assays with the presence of MDP (during plasmid transfection) in 293T cells, which showed that the binding between bjALP2 and bjTRAF6 was weakened by the addition of MDP in a dose-dependent manner (Fig. 6H) . Using luciferase reporter assays, we observed that the presence of MDP did reverse the inhibitory effect of bjALP2 on bjTRAF6-dependent NF-κB activation in a dose-sensitive fashion (Fig. 6I) . In summary, our functional data indicate that the recognition of PGN/MDP by cytoplasmic bjALP2 freed bjTRAF6 from the binding with bjALP2 and released bjTRAF6, which subsequently activated the downstream NF-κB pathway.
Discussion and Conclusions
Apextrin and its homologs have been repeatedly documented since 1998, but their structures and functions have remained elusive (30, 31, (35) (36) (37) (38) (39) (40) (41) (42) . Here, we demonstrate that ALPs contain ApeC, a novel protein domain structure that is conserved in several invertebrate lineages and capable of recognizing the bacterial cell wall component PGN and its moiety MDP. Without the crystal structure of ApeC we cannot rule out the possibility that there are distant ApeC homologs in vertebrates and several other invertebrates (C. elegans, Drosophila, and urochordates). Regardless, ApeC is an ancient domain type that can be dated back to the common ancestor of eumetazoa.
Comprehensive functional analyses revealed the role of two amphioxus ALPs and their ApeC domains in gut mucosal immune responses (Fig. 7) . Briefly, a huge amount of ALP1 is secreted into the gut lumen to protect the epithelium, together with other extracellular effectors. ALP1 aggregates and immobilizes Gram-positive bacteria and hence most likely facilitates the killing and excreting of these bacteria. ALP2, however, is retained within epithelial cells by an unknown mechanism that likely arose through adaptive evolution. ALP2 binds with TRAF6 and prevents TRAF6 from self-ubiquitination and hence from NF-κB activation. Endoplasmic PGN/MDP competes with TRAF6 for ALP2, which releases a sufficient amount of free TRAF6 to activate the NF-κB pathway.
Based on the current information, we can conceive a possible interplay between the two amphioxus ALPs. During bacterial infection in the gut a large amount of PGN and MDP may enter the cytoplasm of gut epithelial cells via the pinocytosis of PGN/MDP or phagocytosis of the bacteria. PGN/MDP binds with ALP2 and releases a sufficient amount of free TRAF6 to activate the NF-κB pathway. In return, NF-κB most likely induces the expression of ALP1. If so, ALP1 will help to quickly clear out the bacteria in the gut lumen and hence reduce the amount of PGN/MDP that ALP2 can access. ALP2 will then rebind TRAF6 to suppress NF-κB. As low NF-κB activity reduces the expression of ALP1, new homeostasis will be achieved at the end of the antibacterial response.
In conclusion, the discovery of the novel ApeC domain (Pfam accession no. PF16977) and the functional information of two amphioxus ALPs define ALPs as a previously unidentified type of PRP. Furthermore, we demonstrate that amphioxus ALPs can serve as extracellular effector PRPs and intracellular sensor PRPs, which provides new insight into the importance and diversified function of ALPs in different animal phyla or subphyla.
Materials and Methods
Twenty amphioxi were maintained in 100 mL filtered seawater, and S. aureus and V. anguillarum were added to the seawater to a final concentration of ∼1 × 10 7 cfu/mL with or without 0.5 μg/mL anti-bjALP1 antibody. Dead amphioxi were counted at the indicated time points after bacterial infection. Purified IgGs from preimmunized mouse serum were used as the control. All primers used in this study are shown in Table S1 .
